- Supported exchanges /
- TW /
- 6598.TW
Applied BioCode (6598 TW) stock market data APIs
Applied BioCode Corporation designs, develops, and commercializes multiplex diagnostic testing products in California. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB. It develops assays, such as BioCode SARS-CoV-2 Assay, a nucleic acid assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; and CoV-2 Flu Assay for detection of RNA and various Influenza, as well as offers gastrointestinal and respiratory pathogen panel related products. In addition, the company provides general purpose reagents and manufactures 28 fungal analyte specific reagents. Further, it offers barcoded bead related accessories. Applied BioCode Corporation is based in Santa Fe Springs, California.
Applied BioCode Financial Data Overview
| 22.95 | |
| 23.6 | |
| - | |
| 23.6 | |
| 22.8 | |
| 19.2-33.6 | |
| 2 359 M | |
| 103 M | |
| 417 M | |
| -0.8 | |
| 0.628 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Applied BioCode Fundamental Data is available in our Financial Data APIs
- Net Revenue 417 M
- EBITDA -142 035 008
- Earnings Per Share -2.2
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Applied BioCode Earnings via APIs
- Latest Release 2024-11-06
- EPS/Forecast -0.44
Get Applied BioCode End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
